| Literature DB >> 27222499 |
Francesca Mataloni1, Chiara Badaloni2, Martina Nicole Golini2, Andrea Bolignano3, Simone Bucci2, Roberto Sozzi3, Francesco Forastiere2, Marina Davoli2, Carla Ancona2.
Abstract
BACKGROUND: The evidence on the health effects related to residing close to landfills is controversial. Nine landfills for municipal waste have been operating in the Lazio region (Central Italy) for several decades. We evaluated the potential health effects associated with contamination from landfills using the estimated concentration of hydrogen sulphide (H2S) as exposure.Entities:
Keywords: landfills; residential cohort study; waste
Mesh:
Substances:
Year: 2016 PMID: 27222499 PMCID: PMC5005946 DOI: 10.1093/ije/dyw052
Source DB: PubMed Journal: Int J Epidemiol ISSN: 0300-5771 Impact factor: 7.196
Descriptive individual and environmental characteristics of the cohort members by hydrogen sulphide (H 2 S) exposure
|
Total
|
H
2
S exposure levels (ng/m
3
)
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
<25° perc (<0.77)
|
25°–50° perc (0.77–2.1)
|
50°–75° perc (2.1–4.2)
|
>75° perc (>4.2)
| |||||||
| No. | % | No. | % | No. | % | No. | % | No. | % | |
|
| 242 409 | 100 | 60 927 | 100.0 | 60 775 | 100 | 63 962 | 100 | 56 745 | 100 |
|
| ||||||||||
| Males | 120 232 | 49.6 | 29 781 | 49.0 | 30 137 | 49.6 | 31 979 | 50.0 | 28 335 | 49.9 |
| Females | 122 177 | 50.4 | 31 146 | 51.0 | 30 638 | 50.4 | 31 983 | 50.0 | 28 410 | 50.1 |
|
| ||||||||||
| Alive | 183 060 | 75.5 | 48 306 | 79.3 | 45 948 | 75.6 | 44 673 | 69.8 | 44 133 | 77.8 |
| Migrant | 40 740 | 16.8 | 8 169 | 13.4 | 10 228 | 16.8 | 14 446 | 22.6 | 7 897 | 13.9 |
| Dead | 18 609 | 7.7 | 4 452 | 7.3 | 4 599 | 7.6 | 4 843 | 7.6 | 4 715 | 8.3 |
|
| ||||||||||
| 0–14 | 53 082 | 21.9 | 12 246 | 20.0 | 13 011 | 21.4 | 16 266 | 25.4 | 11 559 | 20.4 |
| 15–44 | 112 754 | 46.5 | 27 380 | 45.0 | 28 383 | 46.7 | 30 661 | 47.9 | 26 330 | 46.4 |
| 45–64 | 50 146 | 20.7 | 13 296 | 22.0 | 12 584 | 20.7 | 11 727 | 18.3 | 12 539 | 22.1 |
| >65 | 26 427 | 10.9 | 8 005 | 13.0 | 6 797 | 11.2 | 5 308 | 8.3 | 6 317 | 11.1 |
|
| ||||||||||
| High | 23 589 | 9.7 | 10 012 | 16.0 | 6 033 | 9.9 | 4 779 | 7.5 | 2 765 | 4.9 |
| Middle-high | 41 955 | 17.3 | 7 843 | 13.0 | 8 834 | 14.5 | 9 548 | 14.9 | 15 730 | 27.7 |
| Medium | 42 286 | 17.4 | 7 447 | 12.0 | 8 588 | 14.1 | 13 958 | 21.8 | 12 293 | 21.7 |
| Middle-low | 50 394 | 20.8 | 5 364 | 9.0 | 16 816 | 27.7 | 17 563 | 27.5 | 10 651 | 18.8 |
| Low | 62 157 | 25.6 | 22 806 | 37.0 | 15 206 | 25.0 | 11 906 | 18.6 | 12 239 | 21.6 |
| Missing | 22 028 | 9.1 | 7 455 | 12.0 | 5 298 | 8.7 | 6 208 | 9.7 | 3 067 | 5.4 |
|
| ||||||||||
| < 11.99 (<50° perc) | 121 222 | 50.0 | 44 371 | 73.0 | 29 696 | 48.9 | 23 986 | 37.5 | 23 169 | 40.8 |
| 11.99–17.69 (50°–90° perc) | 96 369 | 39.8 | 16 556 | 27.0 | 28 967 | 47.7 | 31 661 | 49.5 | 19 185 | 33.8 |
| > 17.69 (>90° perc) | 24 818 | 10.2 | 0 | 0.0 | 2 112 | 3.5 | 8 315 | 13.0 | 14 391 | 25.4 |
|
| ||||||||||
| < = 150 m | 114 698 | 47.3 | 31 842 | 52.0 | 25 876 | 42.6 | 34 506 | 53.9 | 22 474 | 39.6 |
| > 150 m | 127 711 | 52.7 | 29 085 | 48.0 | 34 899 | 57.4 | 29 456 | 46.1 | 34 271 | 60.4 |
|
| ||||||||||
| < = 500 m | 9 428 | 3.9 | 2 908 | 5.0 | 1 087 | 1.8 | 744 | 1.2 | 4 689 | 8.3 |
| > 500 m | 232 981 | 96.1 | 58 019 | 95.0 | 59 688 | 98.2 | 63 218 | 98.8 | 52 056 | 91.7 |
|
| ||||||||||
| 0–1 km | 12 863 | 5.3 | 376 | 1.0 | 2 676 | 4.4 | 1 130 | 1.8 | 8 681 | 15.3 |
| 1–2 km | 50 503 | 20.8 | 1 138 | 2.0 | 9 589 | 15.8 | 28 809 | 45.0 | 10 967 | 19.3 |
| > 2 km | 179 043 | 73.9 | 59 413 | 98.0 | 48 510 | 79.8 | 34 023 | 53.2 | 37 097 | 65.4 |
|
| ||||||||||
| 0–1 km | 5 187 | 2.1 | 0 | 0.0 | 3 | 0.0 | 19 | 0.0 | 5 165 | 9.1 |
| 1–2 km | 21 475 | 8.9 | 2 | 0.0 | 4 225 | 7.0 | 5 835 | 9.1 | 11 413 | 20.1 |
| 2–3 km | 65 386 | 27.0 | 8 372 | 13.7 | 20 588 | 33.9 | 23 627 | 36.9 | 12 799 | 22.6 |
| 3–4 km | 77 722 | 32.1 | 19 739 | 32.4 | 18 787 | 30.9 | 20 217 | 31.6 | 18 979 | 33.4 |
| 4–5 km | 72 639 | 30.0 | 32 814 | 53.9 | 17 172 | 28.3 | 14 264 | 22.3 | 8 389 | 14.8 |
Associations between hydrogen sulphide (H 2 S in quartiles and continuous) and cause specific mortality: number of deaths (No.) hazard ratios (HR) and 95% confidence intervals (95% CI)
| Cause of death (ICD-9-CM) |
H
2
S concentrations
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
<25° percentile
|
25°–50° percentile
|
50°–75° percentile
|
>75° percentile
|
Linear trend
| |||||||||||
| No. | No. | Crude HR | HR | 95% CI | No. | Crude HR | HR | 95% CI | No. | Crude HR | HR | 95% CI | HR | 95% CI | |
| Natural causes (001–799) | 3 701 | 3 946 | 0.98 | 1.01 | (0.96–1.06) | 4 254 | 1.00 | 1.02 | (0.97–1.08) | 4 104 | 0.96 | 0.98 | (0.91–1.05) | 1.00 | (0.98–1.02) |
| All cancers (140–239) | 1 282 | 1 307 | 0.97 | 0.99 | (0.91–1.08) | 1 493 | 1.03 | 1.05 | (0.95–1.16) | 1 452 | 1.00 | 1.03 | (0.91–1.16) | 1.01 | (0.98–1.05) |
| Stomach (151) | 75 | 88 | 1.03 | 0.98 | (0.70–1.37) | 108 | 1.27 | 1.23 | (0.84–1.79) | 105 | 1.00 | 0.88 | (0.54–1.42) | 1.00 | (0.87–1.16) |
| Colorectal (153–154,159) | 154 | 170 | 0.99 | 1.00 | (0.79–1.27) | 176 | 0.96 | 0.97 | (0.74–1.28) | 159 | 0.93 | 0.91 | (0.64–1.28) | 0.97 | (0.87–1.08) |
| Liver (155–156) | 102 | 89 | 0.86 | 0.83 | (0.61–1.13) | 106 | 0.89 | 0.77 | (0.53–1.11) | 89 | 0.74 | 0.76 | (0.48–1.2) | 0.90 | (0.78–1.05) |
| Pancreas (157) | 68 | 64 | 0.92 | 0.93 | (0.64–1.35) | 69 | 0.92 | 0.95 | (0.61–1.49) | 72 | 0.69 | 0.73 | (0.41–1.32) | 0.93 | (0.77–1.11) |
| Larynx (161) | 17 | 15 | 0.81 | 0.72 | (0.33–1.56) | 11 | 0.38 | 0.40 | (0.14–1.14) | 23 | 0.43 | 0.26 | (0.07–0.95) | 0.64 | (0.43–0.97) |
| Lung (162) | 276 | 281 | 0.98 | 1.06 | (0.89–1.27) | 360 | 1.09 | 1.18 | (0.97–1.45) | 361 | 1.19 | 1.34 | (1.06–1.71) | 1.10 | (1.02–1.19) |
| Bladder (188) | 54 | 48 | 0.88 | 0.89 | (0.59–1.36) | 56 | 1.22 | 1.33 | (0.81–2.16) | 50 | 1.01 | 0.94 | (0.5–1.80) | 1.03 | (0.85–1.26) |
| Kidney (189) | 36 | 30 | 0.76 | 0.85 | (0.51–1.43) | 36 | 0.87 | 0.94 | (0.52–1.70) | 31 | 0.70 | 0.86 | (0.41–1.83) | 0.96 | (0.75–1.22) |
| Brain (191) | 23 | 29 | 1.26 | 1.25 | (0.70–2.26) | 38 | 1.63 | 1.63 | (0.84–3.17) | 41 | 1.70 | 1.76 | (0.81–3.81) | 1.22 | (0.95–1.56) |
| Lymphatic and haematopoietic tissue (200–208) | 108 | 115 | 1.03 | 1.16 | (0.87–1.54) | 106 | 0.94 | 0.96 | (0.68–1.35) | 102 | 1.06 | 1.12 | (0.74–1.17) | 1.02 | (0.89–1.16) |
| Cardiovascular diseases (390–459) | 1 457 | 1 681 | 1.02 | 1.05 | (0.97–1.13) | 1 676 | 0.96 | 1.00 | (0.91–1.09) | 1 641 | 0.90 | 0.91 | (0.81–1.02) | 0.98 | (0.94–1.01) |
| Ischaemic heart diseases (410–414) | 512 | 570 | 0.99 | 1.00 | (0.88–1.14) | 574 | 0.86 | 0.91 | (0.78–1.06) | 530 | 0.77 | 0.78 | (0.64–0.95) | 0.93 | (0.87–0.99) |
| Respiratory diseases (460–519) | 256 | 244 | 0.88 | 0.92 | (0.76–1.11) | 279 | 1.15 | 1.13 | (0.90–1.40) | 264 | 1.30 | 1.30 | (0.99–1.70) | 1.09 | (1.00–1.19) |
| Digestive diseases (520–579) | 158 | 163 | 0.93 | 0.97 | (0.77–1.24) | 218 | 1.06 | 1.09 | (0.83–1.41) | 186 | 0.94 | 0.97 | (0.69–1.35) | 1.01 | (0.91–1.12) |
| Urinary system diseases (580–599) | 58 | 92 | 1.49 | 1.54 | (1.08–2.21) | 74 | 1.25 | 1.28 | (0.83–1.97) | 67 | 1.26 | 1.42 | (0.84–2.40) | 1.11 | (0.94–1.30) |
a Reference category
Associations between hydrogen sulphide (H 2 S, in quartiles and continuous) and cardiorespiratory morbidity: number of people hospitalized (No.), hazard ratios (HR) and 95% confidence intervals (95% CI)
| Diagnosis (ICD-9-CM) |
H
2
S concentrations
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
<25° percentile
|
25°–50° percentile
|
50°–75° percentile
|
>75° percentile
|
Linear trend
| |||||||||||
| No. | No. | Crude HR | HR | 95% CI | No. | Crude HR | HR | 95% CI | No. | Crude HR | HR | 95% CI | HR | 95% CI | |
|
| |||||||||||||||
| Cardiovascular diseases (390–459) | 6 666 | 6 090 | 0.99 | 0.99 | (0.95–1.03) | 6 291 | 0.99 | 1.00 | (0.96–1.04) | 6 677 | 1.03 | 1.02 | (0.97–1.07) | 1.00 | (0.99–1.02) |
| Cardiac diseases (390–429) | 3 991 | 3 585 | 0.99 | 0.98 | (0.93–1.03) | 3 580 | 0.97 | 0.98 | (0.92–1.04) | 4 022 | 1.05 | 1.04 | (0.97–1.11) | 1.01 | (0.98–1.03) |
| Ischaemic heart diseases (410–414) | 1 393 | 1 347 | 1.03 | 1.02 | (0.94–1.10) | 1 288 | 0.94 | 0.94 | (0.85–1.03) | 1 426 | 1.01 | 0.99 | (0.88–1.10) | 0.99 | (0.95–1.02) |
| Cerebrovascular diseases (430–438) | 1 635 | 1 482 | 0.98 | 0.98 | (0.91–1.06) | 1 466 | 0.97 | 0.97 | (0.89–1.06) | 1 543 | 0.97 | 0.98 | (0.88–1.10) | 0.99 | (0.96–1.03) |
| Respiratory diseases (460–519) | 4 372 | 4 249 | 0.98 | 0.97 | (0.92–1.01) | 5 628 | 1.02 | 1.01 | (0.96–1.06) | 4 837 | 1.06 | 1.05 | (0.99–1.11) | 1.02 | (1.00–1.03) |
| Acute respiratory infections (460–466,480–487) | 1 447 | 1 441 | 1.00 | 0.96 | (0.89–1.04) | 1 721 | 1.00 | 0.97 | (0.89–1.05) | 1 509 | 1.09 | 1.07 | (0.97–1.18) | 1.02 | (0.98–1.05) |
| COPD (490–492;494;496) | 654 | 592 | 0.96 | 0.94 | (0.84–1.06) | 535 | 0.92 | 0.90 | (0.78–1.04) | 577 | 1.09 | 1.06 | (0.90–1.25) | 1.00 | (0.95–1.05) |
| Asthma (493) | 332 | 355 | 1.01 | 1.00 | (0.86–1.17) | 594 | 1.16 | 1.17 | (0.99–1.38) | 365 | 1.11 | 1.09 | (0.90–1.33) | 1.04 | (0.98–1.11) |
|
| |||||||||||||||
| Respiratory diseases (460–519) | 1 457 | 1 522 | 1.00 | 0.99 | (0.92–1.07) | 2 420 | 1.07 | 1.08 | (0.99–1.17) | 1 499 | 1.10 | 1.11 | (1.01–1.22) | 1.04 | (1.01–1.07) |
| Acute respiratory infections (460–466,480–487) | 573 | 669 | 1.10 | 1.02 | (0.91–1.15) | 925 | 1.15 | 1.10 | (0.97–1.25) | 617 | 1.25 | 1.20 | (1.04–1.38) | 1.06 | (1.02–1.11) |
| Asthma (493) | 257 | 267 | 0.98 | 0.99 | (0.83–1.19) | 506 | 1.23 | 1.29 | (1.06–1.55) | 276 | 1.11 | 1.13 | (0.91–1.41) | 1.07 | (0.99–1.14) |
a Reference category